Insider filing · TEVA
Evan Lippman
EVP, Business Development
profile →
Teva Pharmaceutical Industries Limited
TEVA · Healthcare · 60 filings in 24 months
ticker →
Evan Lippman sold $1.5M of Teva Pharmaceutical Industries Limited (TEVA)
Executed May 14, disclosed May 18, 4 days later.
Value, as filed
$1.5M
41,658 sh across 2 lots
Executed
May 14
the trade date, as filed
Disclosed
May 18
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
ELEvan Lippman (EVP, Business Development) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Teva Pharmaceutical Industries Limited (TEVA). The largest single filing was $1.5M of TEVA (41,658 sh across 2 lots, as filed), executed May 14.
The name
TEVAHealthcare · Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Evan Lippman in TEVA
TEVASALE
Teva Pharmaceutical Industries Limited
$680K18,600 sh × $36.57
Exec Aug 17
Filed Aug 19 · 4:00 PM ET